Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Vinay Rajani of HDFC Sec suggests Oracle Financial Services, Sun Pharma shares to buy
Indian equity markets experienced a significant selloff on May 18, with Sensex and Nifty 50 dropping over 1%. The BSE Sensex fell over 1,000 points, erasing nearly ₹9 lakh crore in investor wealth amid weak global cues and a bearish trend across sectors.
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Performance This Week
Nifty above 23,500 level; pharma shares in demand
At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 228.50 points or 0.31% to 74,837.48. The Nifty 50 index rose 98.85 points or 0.42% to 23,511.40.
Schaeffler India opens computational research infrastructure at FSID, IISC
Schaeffler India has announced the opening of a computational research infrastructure at the Foundation for Science Innovation and Development (FSID), Bengaluru. Part of Schaeffler India's purposeful engagement with IISC, premium research academia, this supported facility strengthens research capabilities by enabling HPC (High- Performance Computing) large-scale simulations, data-intensive modelling and advanced analytics across materials, energy systems, and sustainable mobility. Additionally, these improvements will foster stronger industry collaborations, improved research quality and efficiency, and increased relevance of research in industry projects.
Sensex slumps 847 pts; Nifty trades below 23,950 mark; VIX rallies 8.40%
The Nifty slipped below the 23,950 mark. Pharma, IT and FNCG shares advanced while all the sectoral indices on the NSE traded in the red.
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Insights
Sun Pharmaceutical receives credit ratings from CRISIL and ICRA
Sun Pharmaceutical Industries (Sun Pharma) announced that CRISIL has reaffirmed the rating of the company's long term bank facilities at CRISIL AAA and short term bank facilities and commercial paper at CRISIL A1+.
Sun Pharma, 5 stocks hit 52-week highs, rally up to 25% in a month
Sensex surged 940 points as six BSE 100 stocks hit 52-week highs, signalling strong bullish momentum. Stocks like Adani Ports, Nestle India and Sun Pharma led gains, supported by solid monthly performance and positive investor sentiment in a rising market
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — 4 May 2026
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Reliance, Kotak Mahindra Bank, and Sun Pharma
Market end sharply lower; Nifty settles below 24,000 mark
Metal, PSU Bank and consumer durables shares declined while IT and Pharma stocks advanced.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Coal India, UltraTech, Sun Pharma, PSU banks: Mayuresh Joshi’s stock calls
Mayuresh Joshi, Director Research, Marketsmith India, says Coal India’s weak volumes and realisations limit upside despite about 6% yield, while UltraTech’s double-digit volume outlook supports steady performance. He flags near-term demand risks for Jindal Stainless but sees long-term potential, prefers pipe plays like Welspun Corp, and remains selective on PSU banks. On Sun Pharma, he sees long-term gains but near-term execution and margin risks.